ARQT
Arcutis Biotherapeutics Inc
Price:  
13.15 
USD
Volume:  
2,225,520.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arcutis WACC - Weighted Average Cost of Capital

The WACC of Arcutis Biotherapeutics Inc (ARQT) is 9.4%.

The Cost of Equity of Arcutis Biotherapeutics Inc (ARQT) is 10.05%.
The Cost of Debt of Arcutis Biotherapeutics Inc (ARQT) is 7.00%.

Range Selected
Cost of equity 7.00% - 13.10% 10.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.8% - 12.1% 9.4%
WACC

Arcutis WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 1.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 13.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.14 0.14
Cost of debt 7.00% 7.00%
After-tax WACC 6.8% 12.1%
Selected WACC 9.4%